Akari Therapeutics Announces $7.6M Private Placement Offering Led By Existing Shareholders And Insiders Of 6,637,626 Unregistered American Depository Shares At A Price Of $0.87 Per ADS

BenzingaMar 3 09:10 ET

Akari Therapeutics Announces $7.6 Million Private Placement Offering Led by Existing Shareholders and Insiders Priced at the Market Under Nasdaq Rules

GlobeNewswireMar 3 09:00 ET

Akari Therapeutics Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference

GlobeNewswireFeb 19 09:00 ET

Virtual Investor "Top 5 for '25" Conference Hosted by JTC Now Available On-Demand

AccesswireFeb 19 08:55 ET

Akari Therapeutics Joins Webull Corporate Connect Service Platform

Akari TherapeuticsFeb 3 00:00 ET

ADRs End Lower; Akari Therapeutics PLC Declines 19%

Dow JonesJan 31 16:30 ET